04.18.2007
HealthShares™ Announces Changes to the HealthShares™ Neuroscience and Composite Indices
New York (April 18, 2007) – HealthShares™ Inc., an investment company with a series
of 20 underlying fund portfolios, today announced it has been informed by Standard &
Poor’s, the calculating agent for the HealthShares™ Indices, that effective at the opening
of trading on Monday April 23, 2007, Neurochem Inc. (Nasdaq: NRMX) will
replace New River Pharmaceuticals (Nasdaq: NRPH) in the HealthShares™
Neuroscience Index. Additionally, Aspreva Pharmaceuticals Corp. (Nasdaq: ASPV) will
replace New River Pharmaceuticals in the HealthShares™ Composite Index. Companies
included in the Neuroscience Index are engaged in the research, clinical development and
commercialization of therapeutic agents for the treatment of a wide variety of
neurological and psychiatric disorders including Alzheimer’s, Parkinson’s, Huntington’s,
schizophrenia, anxiety, depression, epilepsy, pain and sleep disorders.
HealthShares™ Announces Changes to the HealthShares™ Neuroscience and Composite Indices
<< back to news